PPDPF contains:
SH2 domains: Mediate protein-protein interactions by binding phosphorylated tyrosine residues.
SH3 domains: Facilitate interactions with proline-rich motifs.
CLK2 kinase-binding site: Links PPDPF to RNA splicing and cell cycle regulation .
| Domain | Role in Signaling/Function | Reference |
|---|---|---|
| SH2 | Phosphotyrosine-dependent interactions | |
| SH3 | Proline-rich motif recognition | |
| CLK2-binding | Spliceosome regulation, cell cycle control |
PPDPF suppresses cell cycle inhibitors (p21, p27) to promote progenitor proliferation .
In humans, PPDPF overexpression correlates with pancreatic cancer progression and poor prognosis .
In Salmo salar, PPDPF homologs may regulate analogous pathways during smoltification or immune responses, though direct evidence remains sparse .
Upregulation: PPDPF mRNA and protein levels are elevated in HCC vs. normal liver tissues (P = 0.036) .
Prognostic Marker: High PPDPF expression correlates with larger tumor size, recurrence, and reduced survival (19.17 vs. 31.25 months; P = 0.043) .
| Parameter | Association with High PPDPF | P-Value |
|---|---|---|
| Tumor size | Positive | 0.003 |
| Edmondson-Steiner Grade | Positive | 0.021 |
| Recurrence rate | Positive | 0.010 |
PPDPF inhibition during pancreatic differentiation prevents precocious endocrine cell formation, enhancing insulin-producing β-cell generation .
While recombinant Salmo salar PPDPF has not been directly studied, transcriptomic analyses of Atlantic salmon highlight:
Immune Modulation: PPDPF-like genes may interact with pathways involving chemokines, matrix metalloproteinases, and NF-κB during smoltification .
Developmental Regulation: Analogous to human studies, PPDPF could influence cell cycle dynamics in salmonid pancreatic or immune tissues .
Functional Validation: No studies have yet characterized recombinant PPDPF in Salmo salar. Key priorities include:
Cloning and expression of recombinant salmon PPDPF.
Testing its role in pancreatic/liver cell lines or in vivo models.
Comparative Oncology: PPDPF’s oncogenic role in humans warrants investigation in salmonid cancers (e.g., hepatocellular neoplasia) .
KEGG: sasa:100194614
UniGene: Ssa.31009
For effective characterization of PPDPF in Atlantic salmon tissues, a multi-faceted molecular approach is recommended. Begin with RT-PCR for quantitative expression analysis, as this technique has proven reliable for detecting expression levels of similar factors in various tissues. In HCC studies, RT-PCR successfully revealed PPDPF upregulation in cancerous tissues compared to adjacent normal tissues . For protein-level detection, western blot analysis using antibodies specifically developed against salmon PPDPF or cross-reactive antibodies provides confirmation of translation and relative abundance. Immunohistochemistry should be employed for spatial localization within tissues, particularly focusing on pancreatic regions, similar to the approach used in HCC patient samples where PPDPF showed higher expression (54.07%) compared to adjacent normal tissues (24.17%) .
For functional analysis, both gain-of-function and loss-of-function approaches are valuable. Based on methodologies used in cancer studies, RNA interference using shRNAs targeting PPDPF represents an effective approach. Example target sequences that could be adapted (with appropriate modifications for salmon-specific sequences) include: 5'-CCGGTCCTGACCTGAGCGGTTACCACTCGAGTGGTAACCGCTCAGGTCAGGATTTTT-3' and 5'-CCGGGGGTTCCACTTCCAGCAACACTCGAGTGTTGCTGGAAGTGGAACCCATTTTT-3' .
Based on established protocols for salmon protein expression, the Drosophila melanogaster S2 cell system presents a promising platform for expressing recombinant Salmo salar PPDPF. This system has been successfully utilized for the expression of Atlantic salmon serum C-type lectin, another cysteine-rich protein requiring proper folding . The molecular approach should involve:
Cloning the Salmo salar PPDPF coding sequence into a vector under the control of the Drosophila metallothionein promoter
Including a hexahistidine tag for purification purposes
Stable transfection into Drosophila S2 cells
Induction of expression using CdCl₂
For purification, a multi-step process is recommended, similar to the approach used for salmon serum lectin, which involved affinity binding followed by metal-affinity chromatography . The functionality of the purified protein should be verified through appropriate bioassays, such as cell proliferation assays or binding studies with potential interaction partners.
Alternative expression systems to consider include mammalian cell lines for improved post-translational modifications and fish cell lines for a more native environment, though each system presents trade-offs between yield, cost, and proper folding.
Designing effective primers and antibodies for Salmo salar PPDPF research requires careful consideration of several factors:
Primer design:
Conduct comprehensive sequence alignment of PPDPF across fish species to identify conserved regions
Design primers in exon-exon junctions to prevent genomic DNA amplification
Validate primer specificity through in silico analysis against the Salmo salar genome
Include appropriate controls including housekeeping genes validated in salmon tissues
Consider potential paralogs resulting from the salmonid-specific genome duplication event
Antibody development:
Select antigenic regions unique to Salmo salar PPDPF based on predicted protein structure
Consider both polyclonal antibodies for sensitivity and monoclonal for specificity
Validate antibodies through multiple techniques including western blotting, immunohistochemistry, and immunoprecipitation
Test cross-reactivity with related proteins, particularly if the structural characteristics of PPDPF include conserved domains
Ensure antibodies function in different experimental conditions (fixed tissues, protein extracts, etc.)
The research approach should incorporate rigorous validation steps, especially since direct characterization of PPDPF in salmon is limited, requiring careful extrapolation from studies in other species.
To identify protein-protein interactions of PPDPF in Salmo salar, several complementary techniques should be employed:
Co-immunoprecipitation (Co-IP): Express tagged versions of salmon PPDPF (such as MYC-PPDPF) and potential interaction partners (Flag-tagged candidates) in appropriate cell systems. The methodology should follow established protocols used for other protein interaction studies, involving:
Cell lysis in appropriate buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% NP-40 with protease and phosphatase inhibitors)
Immunoprecipitation using antibodies coupled to beads
Proximity labeling techniques: BioID or TurboID fusion proteins can be created by fusing the biotin ligase to PPDPF, allowing identification of proximal proteins in living cells. This approach is particularly valuable for detecting transient or weak interactions that might be missed by traditional Co-IP methods.
Yeast two-hybrid screening: Using salmon PPDPF as bait to screen a Salmo salar cDNA library can identify novel interaction partners. This system has the advantage of detecting direct binary interactions, though confirmation in more physiologically relevant systems is necessary.
Based on studies in human cancer cells, PPDPF has been shown to interact with BABAM2, suggesting that homologs of known interaction partners should be prioritized for validation in salmon models . The experimental design should include appropriate controls and validation through multiple independent techniques.
For investigating PPDPF function in Salmo salar through gene editing, several approaches can be considered:
CRISPR-Cas9 system: This represents the most versatile approach for generating targeted modifications in the salmon genome. Implementation should include:
Design of guide RNAs targeting conserved exons of the PPDPF gene
Delivery methods including microinjection into salmon eggs or ex vivo editing of primary cells
Screening strategies to identify successfully edited individuals
Phenotypic analysis focusing on pancreatic development and function
RNA interference: For more rapid assessment of PPDPF function, shRNA-mediated knockdown provides an alternative to permanent genome editing. Based on cancer research methodologies, design shRNAs targeting specific regions of salmon PPDPF mRNA and deliver via plasmid-based expression systems . This approach is particularly useful for cell culture studies or short-term in vivo experiments.
Overexpression studies: Complementary to loss-of-function approaches, overexpression of wild-type or mutant PPDPF can provide insights into gain-of-function effects. This can be achieved through the generation of transgenic salmon or through transient expression systems.
Each approach has distinct advantages and limitations regarding efficiency, specificity, developmental timing, and phenotypic outcomes. A comprehensive understanding of PPDPF function would benefit from multiple complementary approaches.
High-throughput proteomics offers powerful tools for understanding PPDPF networks in Salmo salar:
Interaction network mapping:
Immunoprecipitation coupled with mass spectrometry (IP-MS) using tagged PPDPF as bait
Proximity labeling approaches (BioID/TurboID) to identify proteins in spatial proximity to PPDPF
Quantitative interaction proteomics comparing wild-type vs. mutant forms of PPDPF
Global proteome changes:
Differential protein expression analysis in PPDPF-knockdown vs. control samples
Temporal proteomic profiling during pancreatic development or disease progression
Analysis of subcellular fractions to determine compartment-specific interactions
Post-translational modification analysis:
Identification of modifications on PPDPF (phosphorylation, ubiquitination, etc.)
Changes in the phosphoproteome or ubiquitinome in response to PPDPF modulation
The experimental design should include appropriate biological and technical replicates, with careful selection of control samples. Data analysis should incorporate pathway enrichment, protein-protein interaction network analysis, and integration with transcriptomic data when available. This systems-level approach would provide comprehensive insights into PPDPF function beyond what can be achieved through targeted studies alone.
The function of PPDPF in Salmo salar pancreatic development likely shares conserved elements with its mammalian counterparts while exhibiting fish-specific adaptations. To investigate these similarities and differences:
Developmental expression analysis:
Perform temporal expression profiling throughout salmon development, from embryonic stages through juvenile and adult phases
Compare expression patterns with known pancreatic development markers
Conduct in situ hybridization to precisely localize PPDPF expression within developing pancreatic tissue
Functional studies:
CRISPR/Cas9 knockout or knockdown models to assess effects on pancreatic development
Analyze the impact on differentiation of endocrine versus exocrine pancreatic cells
Assess potential compensatory mechanisms through paralogs resulting from the salmonid-specific genome duplication
This comparative approach would not only enhance our understanding of PPDPF in salmon but could also provide evolutionary insights into pancreatic development across vertebrates.
The potential role of PPDPF in pancreatic diseases of Atlantic salmon warrants investigation given the significant impact of these conditions on aquaculture:
Expression analysis during infection:
Monitor PPDPF expression changes following experimental infection with IPNV or SAV
Compare expression patterns in resistant versus susceptible salmon strains
Correlate expression levels with disease progression and severity
Infectious pancreatic necrosis (IPN) causes cellular necrosis and loss of pancreatic tissue in Atlantic salmon, particularly in the post-smolt stage in seawater . Similarly, pancreas disease (PD) caused by salmonid alphavirus (SAV) induces necrosis in pancreatic tissue along with inflammation in cardiac and skeletal muscles . Given that PPDPF has shown antiapoptotic properties in human cancer cells , it might play a protective role against virus-induced cell death in salmon pancreatic tissue.
Functional investigation:
Test whether modulation of PPDPF expression affects viral replication or cytopathic effects
Assess if recombinant PPDPF administration can reduce tissue damage in infection models
Determine if PPDPF is involved in pancreatic regeneration following disease-induced damage
Understanding PPDPF's role could provide new targets for intervention strategies against these economically important diseases in salmon aquaculture.
The potential application of recombinant PPDPF in vaccine strategies for salmon pancreatic diseases could be approached through several avenues:
As an adjuvant or immunomodulator:
If PPDPF influences cell survival and proliferation pathways, it might serve as an immunomodulator when combined with conventional vaccines. Current vaccination strategies against pancreatic diseases include inactivated virus vaccines and DNA vaccines, with the latter showing promising reductions in PD outbreaks . Recombinant PPDPF could potentially enhance these approaches through:
Co-administration with viral antigens to promote appropriate immune responses
Incorporation into delivery systems targeting pancreatic tissue
Formulation with existing vaccines to enhance duration of immunity
Within expression vectors:
Previous research has demonstrated that a salmonid alphavirus (SAV) replicon expressing IPNV polyprotein (pSAV/PP) induced modest protection against IPN in Atlantic salmon . A similar approach could be explored with PPDPF:
Creating recombinant viral vectors expressing both viral antigens and PPDPF
Developing DNA vaccines encoding both protective antigens and PPDPF
Testing whether co-expression enhances protective immune responses
Understanding the structural features of PPDPF conserved between humans and Salmo salar requires a detailed comparative analysis:
Sequence analysis:
Perform multiple sequence alignment of PPDPF proteins across species
Identify conserved domains, motifs, and critical residues
Map conservation patterns onto predicted three-dimensional structures
Studies in human cancer models have shown that PPDPF promotes cell growth, colony formation, and invasion while inhibiting apoptosis through mechanisms including BABAM2 stabilization . The conserved structural elements between human and salmon PPDPF would likely mediate similar core functions, while divergent regions might reflect species-specific adaptations.
Functional domains:
The protein interaction domains responsible for BABAM2 binding in humans should be examined for conservation in salmon
Post-translational modification sites, including phosphorylation and ubiquitination sites
Signal peptides or localization sequences that determine subcellular distribution
Experimental validation:
Generate chimeric proteins combining domains from human and salmon PPDPF to test functional conservation
Perform site-directed mutagenesis of conserved residues to assess their importance
Use structural biology approaches (X-ray crystallography, cryo-EM) to determine three-dimensional structures
This structure-function analysis would provide fundamental insights into PPDPF biology across species and guide targeted functional studies.
Determining the three-dimensional structure of Salmo salar PPDPF requires a strategic approach utilizing multiple structural biology techniques:
Protein production for structural studies:
Expression optimization in systems capable of proper folding, such as Drosophila S2 cells that have proven successful for other salmon proteins
Scale-up to obtain sufficient quantities (milligram amounts) of pure, homogeneous protein
Assessment of protein stability and monodispersity through techniques like dynamic light scattering
X-ray crystallography approach:
Crystallization screening using commercial and custom conditions
Optimization of crystallization conditions to obtain diffraction-quality crystals
Data collection at synchrotron facilities and structure determination
Molecular replacement using related structures if available, or experimental phasing
Nuclear magnetic resonance (NMR) spectroscopy:
For smaller domains or the complete protein if size permits
Isotopic labeling (¹⁵N, ¹³C) of recombinant protein in suitable expression systems
Multi-dimensional NMR experiments to assign resonances and determine constraints
Structure calculation and refinement
Cryo-electron microscopy:
Particularly valuable if PPDPF forms larger complexes with interaction partners
Sample preparation on EM grids, vitrification, and data collection
Image processing and 3D reconstruction
Integrative approaches:
The structural information obtained would provide critical insights into PPDPF function and guide structure-based design of tools to modulate its activity.
Post-translational modifications (PTMs) often play crucial roles in regulating protein function. To determine how PTMs affect Salmo salar PPDPF:
Identification of PTM sites:
Mass spectrometry-based proteomics to identify phosphorylation, glycosylation, ubiquitination, and other modifications
Enrichment strategies for specific PTMs (phosphopeptide enrichment, ubiquitin remnant profiling)
Temporal analysis of PTM changes under different physiological conditions
Site-directed mutagenesis:
Generate point mutations at identified PTM sites (e.g., phosphomimetic mutations)
Express wild-type and mutant proteins in appropriate cellular contexts
Compare functional properties including:
Protein stability and turnover
Subcellular localization
Interaction with binding partners
Effects on downstream signaling
Kinase/enzyme identification:
Determine which enzymes are responsible for specific PTMs
Inhibitor studies to assess the functional consequences of preventing specific modifications
In vitro enzymatic assays to confirm direct modification
PTM-specific antibodies:
Develop antibodies recognizing specific PTM states of PPDPF
Use these for detection of modified forms in different physiological contexts
Apply in immunoprecipitation to isolate specifically modified subpopulations
This comprehensive approach would provide detailed insights into how PTMs regulate PPDPF function in salmon, potentially revealing mechanisms of regulation that could be targeted for intervention in disease conditions.
Understanding PPDPF function could contribute to improved disease resistance in salmon aquaculture through several pathways:
Disease biomarker development:
If PPDPF expression changes precede clinical signs of pancreatic diseases, it could serve as an early biomarker
Monitoring PPDPF levels or modifications might enable early intervention before significant losses occur
Develop rapid detection methods suitable for field use in aquaculture settings
Genetic selection programs:
Identify genetic variants in PPDPF or its regulatory regions associated with disease resistance
Include these markers in selective breeding programs for improved stock resilience
Use genotyping to identify individuals with favorable PPDPF variants
Therapeutic targets:
If PPDPF promotes cell survival during infections, enhancing its expression or activity could reduce tissue damage
Conversely, if certain viruses exploit PPDPF-dependent pathways, targeted inhibition might reduce viral replication
Development of small molecules or biologics targeting PPDPF or its interaction partners
Pancreatic diseases like IPN and PD remain significant challenges in salmon aquaculture despite vaccination efforts . Current vaccines, including inactivated virus and DNA vaccines, have contributed to reducing disease occurrence, but outbreaks continue to occur frequently . Novel approaches based on understanding host factors like PPDPF could complement existing strategies to further reduce economic losses.
To determine if PPDPF modulation can enhance vaccine efficacy against pancreatic diseases in salmon, a systematic research approach is needed:
In vitro screening studies:
Develop cell culture models representing salmon pancreatic tissue
Test how PPDPF modulation affects cellular responses to viral antigens
Measure parameters including cytokine production, antigen presentation, and cell survival
Recombinant vaccine formulations:
Develop vaccine constructs co-expressing viral antigens and PPDPF
Compare against conventional vaccines expressing only viral antigens
Test in SAV replicon systems, which have shown promise for IPNV antigen delivery
Challenge trial design:
Vaccinate salmon with conventional vaccines versus PPDPF-enhanced formulations
Challenge with virulent IPNV or SAV strains following established protocols
Assess protection through:
Survival rates
Viral load measurements using RT-PCR
Histopathological examination of pancreatic tissue
Immune response parameters (antibody titers, cell-mediated responses)
Mechanism investigation:
Determine whether PPDPF enhances innate immune responses, adaptive immunity, or tissue resilience
Assess duration of immunity with and without PPDPF inclusion
Evaluate potential side effects, including impacts on growth performance
This research approach would provide concrete evidence regarding whether PPDPF modulation represents a viable strategy for improving vaccine efficacy against economically important pancreatic diseases in salmon aquaculture.
Research findings on PPDPF in Salmo salar can be translated to other commercially important aquaculture species through a strategic approach:
Comparative genomics and proteomics:
Identify PPDPF orthologs in other aquaculture species (trout, sea bass, tilapia, etc.)
Determine sequence conservation and predicted structural similarities
Assess expression patterns across species to identify conserved regulatory mechanisms
Cross-species validation:
Test whether methodologies developed for salmon PPDPF (antibodies, expression systems, functional assays) can be applied to other species
Validate key findings from salmon models in selected representative species
Identify species-specific adaptations versus conserved functions
Disease relevance mapping:
Determine which pancreatic or other diseases in different aquaculture species might involve PPDPF
Assess whether similar mechanisms operate across species boundaries
Develop targeted intervention strategies based on disease mechanism commonalities
Technology transfer:
Adapt recombinant protein production systems established for salmon proteins to other species
Develop broadly applicable detection methods for PPDPF across multiple species
Create modular vaccine platforms that can incorporate PPDPF components for different target species
The successful expression of recombinant salmon serum lectin in Drosophila S2 cells provides a technological foundation that could be adapted for PPDPF production across species. Similarly, knowledge gained about protein-protein interactions and functional domains of salmon PPDPF could guide targeted studies in other species, accelerating research progress.
Several emerging technologies hold promise for accelerating PPDPF research in salmon models:
Single-cell technologies:
Single-cell RNA sequencing to identify cell-specific expression patterns of PPDPF during development and disease
Single-cell proteomics to characterize protein expression at cellular resolution
Spatial transcriptomics to map PPDPF expression in tissue contexts while preserving spatial relationships
Advanced genome editing:
Prime editing and base editing for precise modifications without double-strand breaks
Inducible CRISPR systems for temporal control of gene editing
Tissue-specific promoters for targeted editing in pancreatic cells
Organoid and ex vivo systems:
Development of salmon pancreatic organoids to model development and disease
Microfluidic systems for controlled exposure to pathogens and test compounds
Ex vivo tissue culture systems for short-term experimental manipulations
In vivo imaging:
Reporter systems for real-time visualization of PPDPF expression
Intravital microscopy adaptations for live salmon imaging
PET/CT imaging with labeled antibodies or ligands to track protein distribution
Machine learning applications:
Prediction of protein-protein interactions involving PPDPF
Analysis of complex phenotypic data from high-throughput experiments
Integration of multi-omics datasets to identify regulatory networks
These technologies would enable more precise, efficient, and comprehensive studies of PPDPF biology in salmon, potentially leading to breakthroughs in understanding pancreatic development and disease resistance.
Several critical questions about PPDPF in Salmo salar remain unanswered and require interdisciplinary approaches:
Developmental biology questions:
How does PPDPF contribute to pancreatic development in salmon, and how does this differ from mammals?
What signaling pathways interact with PPDPF during organogenesis?
How is PPDPF expression regulated during the parr-smolt transformation, a critical developmental transition in salmon?
Immunology and disease resistance:
Does PPDPF play a role in the innate immune response to viral infections like IPNV and SAV?
How does PPDPF expression change during infection, and does this contribute to pathogenesis or protection?
Can modulation of PPDPF enhance immune responses to vaccination?
Molecular evolution and adaptation:
How has PPDPF function evolved in salmonids following the salmonid-specific genome duplication?
Are there salmon-specific adaptations in PPDPF structure or function?
How do environmental factors like temperature and salinity affect PPDPF expression and function?
Translational research questions:
Can PPDPF be targeted to enhance disease resistance in aquaculture?
Does PPDPF contribute to pancreatic tissue regeneration following disease-induced damage?
How do different aquaculture conditions affect PPDPF expression and pancreatic health?
Addressing these questions requires collaboration between developmental biologists, immunologists, protein biochemists, evolutionary biologists, and aquaculture specialists. Integrated approaches combining genomics, proteomics, functional studies, and field trials would be necessary to comprehensively understand PPDPF biology in salmon.
Systems biology approaches offer powerful frameworks for understanding PPDPF within the broader context of salmon health and disease:
Multi-omics integration:
Combine transcriptomics, proteomics, metabolomics, and epigenomics data to create comprehensive molecular profiles
Track system-wide changes following PPDPF modulation
Identify regulatory networks controlling PPDPF expression and mediating its effects
Network analysis:
Construct protein-protein interaction networks centered on PPDPF
Identify key hubs and bottlenecks in these networks that might represent intervention targets
Compare network structures across health and disease states
Mathematical modeling:
Develop quantitative models of PPDPF-involved pathways
Simulate perturbations to predict outcomes of experimental interventions
Refine models iteratively based on experimental validation
Phenomic approaches:
High-dimensional phenotyping of PPDPF-modified salmon
Correlation of molecular data with physiological parameters and disease outcomes
Identification of biomarker signatures predictive of disease resistance or susceptibility
Comparative systems approaches:
Apply identical analytical pipelines across multiple species to identify conserved systems
Distinguish species-specific adaptations from core conserved networks
Leverage insights from model organisms to guide salmon research
These systems-level approaches would place PPDPF within its broader biological context, revealing emergent properties not apparent from reductionist studies alone. This comprehensive understanding could lead to novel strategies for enhancing salmon health in aquaculture settings while advancing fundamental knowledge of pancreatic biology across vertebrate species.